Latest Breaking News On - James breitmeyer - Page 1 : vimarsana.com

Oncternal Therapeutics, Inc (NASDAQ:ONCT) Q1 2024 Earnings Call Transcript

Oncternal Therapeutics, Inc (NASDAQ:ONCT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

Carl byrnesSalim yazjiRichard vincentKemp dolliverRobert burnsJim breitmeyerJames breitmeyerHartaj singhOncternal therapeutics incOppenheimer companyInternational studentsOncternal therapeuticsCall transcript mayFirst quarterChief financialSafe harbor

Oncternal Therapeutics To Participate In Oppenheimer 34Th Annual Healthcare Life Sciences Conference

Oncternal Therapeutics To Participate In Oppenheimer 34Th Annual Healthcare Life Sciences Conference
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Richard vincentCorey davisJames breitmeyerOppenheimer coOncternal therapeutics incHealthcare life sciences conferenceChief executive officerAnnual healthcare life sciences conferenceClick hereReceptor tyrosine kinase like orphan

Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference

Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Investorsrichard vincentJames breitmeyerMediacorey davisOppenheimer coHealthcare life sciences conferenceformatHealthcare life sciences conferenceOncternal therapeutics incChief executive officerAnnual healthcare life sciences conferenceAnnual healthcare life sciences conferenceformatFireside chatpresentation dateOncternal therapeuticsoncternal therapeuticsReceptor tyrosine kinase like orphanCorey davisLifesci advisors

Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference

Oncternal Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

James breitmeyerRichard vincentCorey davisOncternal therapeutics incHealthcare life sciences conferenceOppenheimer coAnnual healthcare life sciencesChief executive officerAnnual healthcare life sciences conferenceReceptor tyrosine kinase like orphan

Oncternal Therapeutics, Inc (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript November 9, 2023 Oncternal Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.15. Operator: Greetings and welcome to Oncternal Therapeutics third-quarter 2023 financial results conference call. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like to […]

City ofUnited kingdomSalim yazjiJames breitmeyerCarl byrnesMatthew smithEvan yuFred hutchRichard vincentProfessor johann de bonoMass generalNorthland capitalNanotechnology stocks to buyPerforming dividendOncternal therapeuticsR james breitmeyer